Esomeprazole [clinicaltrials_resource:1442a6e2b3550d28837361b5438ec5b1]
clinicaltrials:NCT00069823Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome [clinicaltrials:NCT00079833]clinicaltrials:NCT00120315Comparison of Esomeprazole to Aerosolized, Swallowed Fluticasone for Eosinophilic Esophagitis [clinicaltrials:NCT00123656]A Comparison of Gastric pH Control With High Dose Intravenous or Oral Esomeprazole [clinicaltrials:NCT00164788]On Demand Treatment of Reflux Disease [clinicaltrials:NCT00184522]Acid-Associated Heartburn Symptoms and Dose of Esomeprazole [clinicaltrials:NCT00206024]Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po [clinicaltrials:NCT00206050]NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis [clinicaltrials:NCT00206180]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. [clinicaltrials:NCT00206245]A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. [clinicaltrials:NCT00206284]clinicaltrials:NCT00206440The Effect of Nexium on Transmucosal Esophageal Leak [clinicaltrials:NCT00216788]Evaluation of Esomeprazole in Treating Gastro-Esophageal Reflux Disease (GERD) in Head and Neck Cancer Patients Exposed to Radiation Therapy [clinicaltrials:NCT00222079]Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients [clinicaltrials:NCT00222131]The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep [clinicaltrials:NCT00225238]Esomeprazole for Treatment of GERD in Pediatric Patients [clinicaltrials:NCT00228527]Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects [clinicaltrials:NCT00230516]Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients [clinicaltrials:NCT00241501]Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [clinicaltrials:NCT00241514]Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [clinicaltrials:NCT00241527]Esomeprazole for Relief of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [clinicaltrials:NCT00241540]Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs [clinicaltrials:NCT00241553]An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD) [clinicaltrials:NCT00242736]HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease [clinicaltrials:NCT00243724]Chest Pain Pilot Study [clinicaltrials:NCT00251901]Nexium Dyspepsia/AST [clinicaltrials:NCT00251914]clinicaltrials:NCT00251927ASTERIX: Low Dose ASA and Nexium [clinicaltrials:NCT00251966]A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer [clinicaltrials:NCT00251979]Nexium Dyspepsia/AST [clinicaltrials:NCT00251992]Esomeprazole in PPI Failures - IMPROVE [clinicaltrials:NCT00272701]clinicaltrials:NCT00287339Validation of RDQ Questionnaire [clinicaltrials:NCT00291746]clinicaltrials:NCT00317044Nexium RESPONSE Trial [clinicaltrials:NCT00318968]AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers [clinicaltrials:NCT00325715]A Phase I Study of BMS-275183 (Oral Taxane) Given on a Daily Schedule in Combination With Esomeprazole (Nexium) in Patients With Advanced Cancer [clinicaltrials:NCT00332748]Symptom Adapted Therapy in GERD Patients [clinicaltrials:NCT00343161]An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus Patients [clinicaltrials:NCT00352261]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Esomeprazole [clinicaltrials_resource:1442a6e2b3550d28837361b5438ec5b1]
Bio2RDF identifier
1442a6e2b3550d28837361b5438ec5b1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1442a6e2b3550d28837361b5438ec5b1
identifier
clinicaltrials_resource:1442a6e2b3550d28837361b5438ec5b1
title
Esomeprazole
@en
type
label
Esomeprazole [clinicaltrials_resource:1442a6e2b3550d28837361b5438ec5b1]
@en